search
Back to results

Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The ImPACT Program (ImPACT)

Primary Purpose

Brain Cancer, Cognitive Impairment

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
ImPACT program
Sponsored by
Aarhus University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brain Cancer focused on measuring Brain Cancer, Brain Tumor, Cognitive Impairment, Neurobehavioral Impairment, Neuropsychological Rehabilitation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosis of brain cancer Completed primary treatment at least 6 months ago Medically stable Speaks and understand Danish Living with a carer aged 18 or over, who also speaks and understands Danish and consents to participate in the study alongside the patient Exclusion Criteria: โ€ข Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment

Sites / Locations

  • Aarhus University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

ImPACT program

Waitlist

Arm Description

The ImPACT program consists of 8 weekly 1-hour sessions with homework between sessions.

Waitlist control

Outcomes

Primary Outcome Measures

Self-reported cognitive functioning
The Patients Assessment of Own Functioning Inventory (PAOFI). 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Carer-reported cognitive functioning
The Patients Assessment of Own Functioning Inventory (PAOFI) modified to informant version. 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Self-reported neurobehavioral functioning
The self-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Carer-reported neurobehavioral functioning
The carer-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.

Secondary Outcome Measures

Self-reported cognitive functioning
The Patients Assessment of Own Functioning Inventory (PAOFI). 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Carer-reported cognitive functioning
The Patients Assessment of Own Functioning Inventory (PAOFI) modified to informant version. 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Self-reported neurobehavioral functioning
The self-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Carer-reported neurobehavioral functioning
The carer-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Objective cognitive functioning (Neuropsychological tests; Patient only)
Global composite z-score based on the HVLT-R; Trail-making tests A and B; WAIS-IV Coding, Digit Span, Verbal Fluency; Conner's Continuous Performance Test III.
Objective cognitive functioning (Neuropsychological tests; Patient only)
Global composite z-score based on the HVLT-R; Trail-making tests A and B; WAIS-IV Coding, Digit Span, Verbal Fluency; Conner's Continuous Performance Test III.
Premorbid intellectual functioning (Patient only)
WAIS-IV Information subtest. 26 items; answer format range 0-1; total score range: 0-26. Higher score indicates higher premorbid intellectual functioning.
Self-reported fatigue
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue). 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Carer-reported fatigue
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue) modified to informant version. 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Self-reported fatigue
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue). 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Carer-reported fatigue
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue) modified to informant version. 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Self-reported mental fatigue
The Mental Fatigue Scale (MFS). 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Carer-reported mental fatigue
The Mental Fatigue Scale (MFS) modified to informant version. 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Self-reported mental fatigue
The Mental Fatigue Scale (MFS). 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Carer-reported mental fatigue
The Mental Fatigue Scale (MFS) modified to informant version. 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Depression (patient only)
The Center for Epidemiologic Studies Depression Scale (CESD). 20 items: answer format range 0-3; total score range: 0-60. Higher score indicates more depression.
Depression (patient only)
The Center for Epidemiologic Studies Depression Scale (CESD). 20 items: answer format range 0-3; total score range: 0-60. Higher score indicates more depression.
Self-reported health-related quality of life
The Functional Assessment of Cancer Therapy-Brain (FACT-Br). 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Carer-reported health-related quality of life
The Functional Assessment of Cancer Therapy-Brain (FACT-Br) modified to informant version. 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Self-reported health-related quality of life
The Functional Assessment of Cancer Therapy-Brain (FACT-Br). 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Carer-reported health-related quality of life
The Functional Assessment of Cancer Therapy-Brain (FACT-Br) modified to informant version. 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Self-reported community integration
The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Carer-reported community integration
The carer-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Self-reported community integration
The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Carer-reported community integration
The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Insomnia
The Insomnia Severity Index (ISI). 7 items; answer format range: 0-4; total score range: 0-28. Higher score indicates more insomnia.
Insomnia
The Insomnia Severity Index (ISI). 7 items; answer format range: 0-4; total score range: 0-28. Higher score indicates more insomnia.
Self-reported participant satisfaction
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Carer-reported participant satisfaction
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Self-reported participant satisfaction
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Carer-reported participant satisfaction
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Self-reported participant motivation
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Carer-reported participant motivation
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Self-reported participant motivation
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Carer-reported participant motivation
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.

Full Information

First Posted
May 1, 2023
Last Updated
July 20, 2023
Sponsor
Aarhus University Hospital
Collaborators
University of Aarhus
search

1. Study Identification

Unique Protocol Identification Number
NCT05858359
Brief Title
Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The ImPACT Program
Acronym
ImPACT
Official Title
Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The "I'm Aware: Patients and Carers Together" (ImPACT) Program"
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2023 (Actual)
Primary Completion Date
June 1, 2025 (Anticipated)
Study Completion Date
June 1, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aarhus University Hospital
Collaborators
University of Aarhus

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the present randomized-controlled study is to evaluate the feasibility, acceptability, and preliminary efficacy of a novel, context-sensitive neuropsychological rehabilitation intervention for brain cancer survivors.
Detailed Description
Cognitive impairment is the most common late effect in brain cancer survivors, with profound negative effects on quality of life, work ability, and socioeconomic outcomes. Still, there is no gold standard approach to treating cognitive impairment in brain cancer survivors. Furthermore, there is a dearth of research on interventions to treat cognitive impairment in brain cancer survivors, and the relatively few studied interventions have proven limited effects. Arguably, four key elements are missing from a majority of studied interventions:1) transfer of learning to real-world functional outcomes, 2) awareness training to enhance compensatory strategy use, 3) inclusion of carers that could enhance transfer of learning to the home, and 4) recognition of the inter-related nature of cognitive, neurobehavioral, and psychological functions. The "I'M aware: Patients and Carers Together (ImPACT)" program is a novel, context-sensitive neuropsychological rehabilitation intervention that targets the above mentioned missing elements in previous rehabilitation efforts. The present feasibility randomized-controlled study aims to evaluate the feasibility, acceptability, and preliminary efficacy of this program in brain cancer survivors with cognitive impairment in preparation for a subsequent large-scale randomized controlled trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Cancer, Cognitive Impairment
Keywords
Brain Cancer, Brain Tumor, Cognitive Impairment, Neurobehavioral Impairment, Neuropsychological Rehabilitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized waitlist controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ImPACT program
Arm Type
Experimental
Arm Description
The ImPACT program consists of 8 weekly 1-hour sessions with homework between sessions.
Arm Title
Waitlist
Arm Type
No Intervention
Arm Description
Waitlist control
Intervention Type
Behavioral
Intervention Name(s)
ImPACT program
Intervention Description
During the ImPACT program, the brain cancer survivor and a carer collaborate on: Becoming aware of the patient's core strengths and difficulties Helping the patient to be optimally responsive to the guidance of the carer, and Creating compensatory strategies to respond to real-world manifestations of the patient's difficulties and helping the patient implement these strategies at home.
Primary Outcome Measure Information:
Title
Self-reported cognitive functioning
Description
The Patients Assessment of Own Functioning Inventory (PAOFI). 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported cognitive functioning
Description
The Patients Assessment of Own Functioning Inventory (PAOFI) modified to informant version. 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported neurobehavioral functioning
Description
The self-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported neurobehavioral functioning
Description
The carer-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Secondary Outcome Measure Information:
Title
Self-reported cognitive functioning
Description
The Patients Assessment of Own Functioning Inventory (PAOFI). 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported cognitive functioning
Description
The Patients Assessment of Own Functioning Inventory (PAOFI) modified to informant version. 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Self-reported neurobehavioral functioning
Description
The self-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported neurobehavioral functioning
Description
The carer-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Objective cognitive functioning (Neuropsychological tests; Patient only)
Description
Global composite z-score based on the HVLT-R; Trail-making tests A and B; WAIS-IV Coding, Digit Span, Verbal Fluency; Conner's Continuous Performance Test III.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Objective cognitive functioning (Neuropsychological tests; Patient only)
Description
Global composite z-score based on the HVLT-R; Trail-making tests A and B; WAIS-IV Coding, Digit Span, Verbal Fluency; Conner's Continuous Performance Test III.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Premorbid intellectual functioning (Patient only)
Description
WAIS-IV Information subtest. 26 items; answer format range 0-1; total score range: 0-26. Higher score indicates higher premorbid intellectual functioning.
Time Frame
Baseline (T1)
Title
Self-reported fatigue
Description
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue). 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported fatigue
Description
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue) modified to informant version. 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported fatigue
Description
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue). 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported fatigue
Description
The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue) modified to informant version. 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Self-reported mental fatigue
Description
The Mental Fatigue Scale (MFS). 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported mental fatigue
Description
The Mental Fatigue Scale (MFS) modified to informant version. 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported mental fatigue
Description
The Mental Fatigue Scale (MFS). 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported mental fatigue
Description
The Mental Fatigue Scale (MFS) modified to informant version. 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Depression (patient only)
Description
The Center for Epidemiologic Studies Depression Scale (CESD). 20 items: answer format range 0-3; total score range: 0-60. Higher score indicates more depression.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Depression (patient only)
Description
The Center for Epidemiologic Studies Depression Scale (CESD). 20 items: answer format range 0-3; total score range: 0-60. Higher score indicates more depression.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Self-reported health-related quality of life
Description
The Functional Assessment of Cancer Therapy-Brain (FACT-Br). 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported health-related quality of life
Description
The Functional Assessment of Cancer Therapy-Brain (FACT-Br) modified to informant version. 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported health-related quality of life
Description
The Functional Assessment of Cancer Therapy-Brain (FACT-Br). 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported health-related quality of life
Description
The Functional Assessment of Cancer Therapy-Brain (FACT-Br) modified to informant version. 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Self-reported community integration
Description
The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported community integration
Description
The carer-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported community integration
Description
The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported community integration
Description
The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Insomnia
Description
The Insomnia Severity Index (ISI). 7 items; answer format range: 0-4; total score range: 0-28. Higher score indicates more insomnia.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Insomnia
Description
The Insomnia Severity Index (ISI). 7 items; answer format range: 0-4; total score range: 0-28. Higher score indicates more insomnia.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Self-reported participant satisfaction
Description
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported participant satisfaction
Description
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported participant satisfaction
Description
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported participant satisfaction
Description
The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Self-reported participant motivation
Description
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Carer-reported participant motivation
Description
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Time Frame
Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Title
Self-reported participant motivation
Description
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Title
Carer-reported participant motivation
Description
The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.
Time Frame
Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]
Other Pre-specified Outcome Measures:
Title
Qualitative Interviews
Description
Following the T4 assessment, participants included in the intervention arm will be invited to participate in a 30-minutes semi-structured, audio recorded interview.
Time Frame
8 weeks after post-intervention (approximately 16 weeks after Baseline assessment (T1): Follow-up, T4)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of brain cancer Completed primary treatment at least 6 months ago Medically stable Speaks and understand Danish Living with a carer aged 18 or over, who also speaks and understands Danish and consents to participate in the study alongside the patient Exclusion Criteria: โ€ข Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lisa M Wu, PhD
Phone
+45 87 15 37 48
Email
lisa.wu@oncology.au.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Cecilie R Buskbjerg, PhD
Phone
+4529842526
Email
cdrc@psy.au.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lisa M Wu, PhD
Organizational Affiliation
Aarhus University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8270
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cecilie DR Buskbjerg, Ph.D.
Phone
29842526
Ext
45
Email
cdrc@psy.au.dk
First Name & Middle Initial & Last Name & Degree
Lisa Wu, Ph.D.

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The ImPACT Program

We'll reach out to this number within 24 hrs